30 Jan 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209526
25 Nov 2022
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210823
16 May 2022
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/news/sanofi-multiple-myeloma-trial/
01 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/halozyme-announces-janssen-receives-us-fda-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-in-combination-with-carfilzomib-and-dexamethasone-for-patients-with-multiple-myeloma-after-first-or-subsequent-relapse-301435510.html
13 Oct 2021
// Mamta Mayani SEEKINGALPHA
https://seekingalpha.com/news/3752261-health-canada-approves-sanofis-sarclisa-combination-for-multiple-myeloma
16 Jun 2021
// BIOSPACE
https://www.biospace.com/article/releases/breckenridge-announces-approval-of-its-anda-for-carfilzomib-intravenous-powder-generic-for-kyprolis-/?s=74#:~:text=BERLIN%2C%20Conn.%2C%20June%2016,(generic%20for%20Kyprolis%C2%AE).